Unlocking the Potential of SCNN1D: A Sodium Channel, voltage-gated, Type I, Delta Polypeptide as a Drug Target

Target Name: SCNN1D

NCBI ID: G6339

SCNN1D

Unlocking the Potential of SCNN1D: A Sodium Channel, voltage-gated, Type I, Delta Polypeptide as a Drug Target

Introduction

SCNN1D (Sodium Channel, Voltage-Gated, Type I, Delta Polypeptide) is a unique protein that has been identified as a potential drug target and biomarker. It is a member of the voltage-gated sodium channel subfamily, which is a widely expressed transmembrane protein that plays a critical role in excitable systems, including neural and cardiorespiratory channels. SCNN1D is unique due to its specific subunit, which consists of a voltage-gated sodium channel that is highly conserved in its amino acid sequence and is expressed in a variety of tissues and cells.

The Sodium Channel as a Drug Target

SCNN1D has been identified as a potential drug target due to its unique structure and its involvement in various physiological processes. The sodium channel is a critical protein that is involved in the regulation of intracellular and extracellular electrical potentials. It is a transmembrane protein that consists of an intracellular portion and an extracellular portion that is involved in the regulation of ion channels.

SCNN1D is a voltage-gated sodium channel that is highly conserved in its amino acid sequence. This conserved sequence allows it to interact with various molecules, including small molecules, peptides, and proteins. The voltage-gated property of SCNN1D allows it to be easily modified and used as a drug.

SCNN1D is also involved in the regulation of various physiological processes, including muscle contractions, nerve impulses, and heart rhythms. It is a critical protein that is involved in the regulation of these processes, and any changes in its function have been linked to a variety of neurological and cardiovascular disorders.

The Potential of SCNN1D as a Drug

The potential of SCNN1D as a drug is due to its unique structure and its involvement in various physiological processes. SCNN1D is a voltage-gated sodium channel that is highly conserved in its amino acid sequence, which makes it an attractive target for small molecules. Additionally , its unique structure allows it to be easily modified and used as a drug.

One of the key advantages of SCNN1D as a drug is its potential to target a variety of diseases. Its voltage-gated property makes it a potential target for a variety of drugs, including muscle relaxants, beta blockers, and neurotransmitters. Additionally, its involvement in various physiological processes makes it a potential target for drugs that are used to treat a wide range of disorders.

Another advantage of SCNN1D as a drug is its unique structure, which makes it a potential design target. The unique structure of SCNN1D allows researchers to easily modify and optimize its function as a drug. This includes the development of small molecules that can interact with specific residues on SCNN1D and enhance its activity.

Conclusion

In conclusion, SCNN1D is a unique protein that has been identified as a potential drug target and biomarker. Its voltage-gated sodium channel structure and its involvement in various physiological processes make it an attractive target for small molecules. The potential of SCNN1D as a drug is due to its unique structure and its involvement in various physiological processes. Further research is needed to fully understand its potential as a drug and to develop safe and effective treatments.

Protein Name: Sodium Channel Epithelial 1 Subunit Delta

Functions: Sodium permeable non-voltage-sensitive ion channel inhibited by the diuretic amiloride. Mediates the electrodiffusion of the luminal sodium (and water, which follows osmotically) through the apical membrane of epithelial cells. Controls the reabsorption of sodium in kidney, colon, lung and sweat glands. Also plays a role in taste perception

The "SCNN1D Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SCNN1D comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets